MedPath

Investigating the effect of two types of time restricted eating on glycemic, lipid indices, appetite, and sleep quality of women with polycystic ovary syndrome

Not Applicable
Recruiting
Conditions
Polycystic Ovary Syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20221122056575N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
75
Inclusion Criteria

Age 18 - 40 years
25 = body mass index(BMI) = 34.9
Women with PCOS diagnosed by the Rotterdam criteria

Exclusion Criteria

pregnant or lactating
night-shift workers,
hypotension
use of medication therapy that impacts carbohydrate or lipid metabolism (oral contraceptive pills, insulin-sensitizers, antiepileptics, statins, fish oil and ...) in the recent 3 months
body weight fluctuations for more than 5% in the past 3 months
Medicines that affect body weight
Regular use of any drug or supplement that affects sleep
Taking drugs that affect appetite at the time of entering the study
Having a special diet
Eating disorders or mental disorders
night eating syndrome
fasting for more than 14 h per day
Congenital adrenal hyperplasia, androgen-secreting tumor, Cushing's syndrome, diabetes, thyroid dysfunction and hyperprolactinemia
Cardiovascular, kidney, liver, lung and nervous diseases, digestive system surgery or food absorption disorders
professional athlete
perimenopausal
Tobacco history
Taking food supplements
Sarcopenia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath